Molecular imaging of carotid plaque with targeted ultrasound contrast

Ultrasound and Carotid Bifurcation Atherosclerosis

Volumn 9781848826885, Issue , 2012, Pages 153-161

  Rychak, Joshua J ^a   Klibanov, Alexander L ^b  

^a Targeson Inc   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930012444     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84882-688-5_9     Document Type: Chapter

References (41)

1. Weissleder R, Mahmood U. Molecular imaging. Radiology. 2001;219(2):316-333.
2. Villanueva FS. Molecular imaging of cardiovascular disease using ultrasound. J Nucl Cardiol. 2008;15(4):576-586.
3. Galkina E, Ley K. Leukocyte influx in atherosclerosis. Curr Drug Targets. 2007;8(12):1239-1248.
4. Hutter JC, Luu HM, Mehlhaff PM, Killam AL, Dittrich HC. Physiologically based pharmacokinetic model for fluorocarbon elimination after the administration of an octafluor-opropane-albumin microsphere sonographic contrast agent. J Ultrasound Med. 1999;18(1):1-11.
5. Harris JR, Depoix F, Urich K. The structure of gas-filled nbutyl- 2-cyanoacrylate (BCA) polymer particles. Micron. 1995;26(2):103-111.
6. Patrianakos AP, Hamilos MI. Drug evaluation: PB-127, a novel contrast agent for the detection of myocardial perfusion. Curr Opin Investig Drugs. 2007;8(3):248-255.
7. Straub JA et al. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J Control Release. 2005;108 (1):21-32.
8. Paradossi G, Cavalieri F, Chiessi E, Ponassi V, Martorana V. Tailoring of physical and chemical properties of macro- and microhydrogels based on telechelic PVA. Biomacromolecules. 2002;3(6):1255-1262.
9. Chlon C et al. Effect of molecular weight, crystallinity, and hydrophobicity on the acoustic activation of polymershelled ultrasound contrast agents. Biomacromolecules. 2009;10(5):1025-1031.
10. Lindner JR et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation. 2000;102(22):2745-2750.
11. Korpanty G, Grayburn PA, Shohet RV, Brekken RA. Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol. 2005;31(9):1279-1283.
12. Kim DH, Klibanov AL, Needham D. The influence of tiered layers of surface-grafted poly(ethylene glycol) on receptorligand- mediated adhesion between phospholipid monolayer- stabilized microbubbles and coated class beads. Langmuir. 2000;16(6):2808-2817.
13. Ham AS, Klibanov AL, Lawrence MB. Action at a distance: lengthening adhesion bonds with poly(ethylene glycol) spacers enhances mechanically stressed affinity for improved vascular targeting of microparticles. Langmuir. 2009;25(17):10038-10044.
14. Klibanov AL et al. Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles. Invest Radiol. 2004;39(3):187-195.
15. Phillips P, Gardner E. Contrast-agent detection and quantification. Eur Radiol. 2004;14(suppl 8):P4-P10.
16. Eckersley RJ, Chin CT, Burns PN. Optimising phase and amplitude modulation schemes for imaging microbubble contrast agents at low acoustic power. Ultrasound Med Biol. 2005;31(2):213-219.
17. Lindner JR et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001;104(17):2107-2112.
18. Rychak JJ et al. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging. 2007;6 (5):289-296.
19. Christiansen JP, Leong-Poi H, Klibanov AL, Kaul S, Lindner JR. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation. 2002;105(15):1764-1767.
20. Dayton P, Klibanov A, Brandenburger G, Ferrara K. Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. Ultrasound Med Biol. 1999;25 (8):1195-1201.
21. Zhao S et al. Radiation-force assisted targeting facilitates ultrasonic molecular imaging. Mol Imaging. 2004;3(3): 135-148.
22. Rychak JJ, Klibanov AL, Hossack JA. Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification. IEEE Trans Ultrason Ferroelectr Freq Control. 2005;52(3):421-433.
23. Rychak JJ, Klibanov AL, Ley KF, Hossack JA. Enhanced targeting of ultrasound contrast agents using acoustic radiation force. Ultrasound Med Biol. 2007;33(7):1132-1139.
24. Patil AV, Rychak JJ, Allen JS, Klibanov AL, Hossack JA. Dual frequency method for simultaneous translation and real-time imaging of ultrasound contrast agents within large blood vessels. Ultrasound Med Biol. 2009;35 (12):2021-2030.
25. Takalkar AM, Klibanov AL, Rychak JJ, Lindner JR, Ley K. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release. 2004;96(3):473-482.
26. Ley K, Gaehtgens P, Spanel-Borowski K. Differential adhesion of granulocytes to five distinct phenotypes of cultured microvascular endothelial cells. Microvasc Res. 1992;43 (2):119-133.
27. Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol. 2007;42(9):643-651.
28. Klibanov AL et al. Targeting of ultrasound contrast material. An in vitro feasibility study. Acta Radiol Suppl. 1997;412:113-120.
29. Villanueva FS et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation. 1998;98(1):1-5.
30. Weller GE, Villanueva FS, Tom EM, Wagner WR. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng. 2005;92(6):780-788.
31. Klibanov AL et al. Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol Imaging. 2006;1(6):259-266.
32. Ottoboni S et al. Characterization of the in vitro adherence behavior of ultrasound responsive double-shelled microspheres targeted to cellular adhesion molecules. Contrast Media Mol Imaging. 2006;1(6):279-290.
33. Kaufmann BA et al. Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol. 2009;30(1):54-59.
34. Ferrante EA, Pickard JE, Rychak J, Klibanov A, Ley K. Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release. 2009;140(2):100-107.
35. Cho YK et al. Dual-targeted contrast enhanced ultrasound imaging of atherosclerosis in apolipoprotein e gene knockout mice. Circulation. 2006;114(18):759.
36. Guenther F, Klibanov AL, Ferrante E, Bode C, von zur Muhlen C. An ultrasound contrast agent targeted towards P-selectin detects activated platelets at supra-arterial shear flow ex-vivo. In: Contrast Media Research Symposium; Copenhagen; 2009:21-23.
37. Schumann PA et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol. 2002;37(11):587-593.
38. Pochon S et al. BR55: a lipopeptide-based VEGFR2- targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol. 2010;45(2):89-95.
39. Staub D et al. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke. 2010;41(1):41-47.
40. Fuster V, Badimon J, Chesebro JH, Fallon JT. Plaque rupture, thrombosis, and therapeutic implications. Haemostasis. 1996;26(suppl 4):269-284.
41. Dunn S et al. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J. 2008;409(2):349-355.